Paediatric Solid Tumour Biology and Therapeutics Group Professor Louis Chesler’s group is investigating the genetic causes for the childhood cancers, neuroblastoma, medulloblastoma and ...

“New breast cancer drug capivasertib is allowing me to live life to the full” – Elen’s story“New breast cancer drug capivasertib is allowing me to live life to the full” – Elen’s story Elen Hughes was ...

Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

Scientists from the ICR have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for ...

Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year.

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.

News from ASCO 2025 From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

A new frontier in cancer research: the rise of radiotheranostics Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer ...

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...